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Abstract
Primary pleural myxoid liposarcoma is a rare entity and no agreed treatment options have been
formulated once diagnosis has been made. We report two cases with subsequent management and
make recommendations for treatment pathways in these rare cases.
Introduction
Liposarcoma is a malignancy arising from fat cells and in
adults it accounts for ten to twelve percent of soft tissue
tumours. It appears mainly as a retroperitoneal or intra-
abdominal mass. However, there are very few cases of pri-
mary intrathoracic liposarcomas arising from within the
mediastinum. They are usually slow growing with an
expansile rather than infiltrative behaviour; hence they
present with pressure related symptoms to their neigh-
bouring structures [1]. We report two cases of primary
pleural liposarcoma complimented by a literature review.
Case 1
A 42-year-old male presented to the respiratory physicians
with an eight-week history of malaise, left sided upper
abdominal pain and increasing shortness of breath. He
had an expectorant cough but no haemoptysis, fever,
chills and rigors. He was a non-smoker with no significant
past medical history.
The chest film [CxR] was suggestive of a large left sided
pleural effusion, and a computerised tomogram [CT] con-
firmed a loculated effusion. A pleural tap was negative for
malignancy and a working diagnosis of left empyema was
made; the patient was referred to the thoracic department
for further management.
At thoracotomy, the left lower lobe was collapsed by a
well-encapsulated pedicled mass arising from the para
aortic region. A frozen section confirmed the malignant
nature of the mass, which was subsequently resected en-
bloc and subjected to histology. The patient had an une-
ventful post operative recovery.
The histological examination revealed a myxoid liposar-
coma with some evidence of differentiation. The patient
was referred onto the sarcoma team, for adjuvant treat-
ment. At follow up, 2 months after surgery, the patient
was making an excellent recovery. The patient however
showed evidence of recurrence at his six month follow up
and went onto have additional surgery and chemother-
apy.
Case 2
An 80-year-old female presented with increasing short-
ness of breath over a period of three months, with an exer-
cise tolerance of fifty metres. There was no associated
cough, haemoptysis or weight loss. On examination there
was decreased air entry on the left side. CxR revealed a
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large left sided pleural effusion and the CT scan showed a
large fluid density mass in the anterior mediastinum. The
patient was discussed in a multi disciplinary meeting and
proceeded to surgery.
An attempted left VATS was initially performed but this
had to be converted to open thoracotomy due to the large
nature of the mass. It was eventually excised confirming
compression of the normal left lung.
Histology revealed a myxoid liposarcoma and positive
resection margins. The patient was deemed not fit for rad-
ical radiotherapy and best supportive care was offered.
She died eight months after diagnosis from disease pro-
gression,
Discussion
A review of medline revealed a total of six reported cases
of primary pleural myxoid liposarcoma [1].
There seems to be a male preponderance [six out of eight]
with the mean age at presentation being 55 years. The
most common presenting feature is dyspnoea and cough,
with an associated pleural effusion in most cases. There is
often evident pleuritic pain and weight loss, although
asymptomatic cases have been reported at presentation
[2,3].
There seems to be no consensus regarding the postopera-
tive management of these patients nor an agreed treat-
ment pathway. Surgery seems to be the most common
option, and offers the best chance of cure or disease con-
trol in these rare cases. Operative mortality though has
been reported to be as high as 40% [4]. Surgical approach
does not influence survival.
Pitson et al showed a 54% tumour response and reduction
after irradiation employing a total of 50gy and 2Gy frac-
tions [4]. Although such responses do not include primary
pleural tumours, similar results could potentially be
duplicated for preoperative tumour reduction of complex
masses or as adjuvant treatment post operatively when
positive margins are confirmed. Indeed the case report
from Wong et al showed that when radiation was offered
a longer disease free interval was noted [2].
According to the current available literature, survival var-
ies between 7 months and 8 years. Nader et al, reported
four patients with primary liposarcoma of which three
were myxoid; two died between seven and nine months
after initial presentation, with only one survivor at time of
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Table 1: Case reports of primary myxoid liposarcoma of the pleural cavity
Study Age Symptoms Treatment Survival
Goldsmith and Papagiannopoulos
Case 1 42 Malaise, dyspnoea, cough Resection + radiotherapy. Recurrence – 
further 
resection + chemotherapy
Alive at one year
Case 2 80 Dyspnoea Resection Died 8 months after Dx
Nader et al
Case 1 45 Bronchitis, pneumonia Resection + Chemotherapy Died 7 months after Dx
Case 2 73 Incidental Pleural effusion on CXR VATS + biopsy, not resected. Palliative care Died 9 months after Dx
Case 3 80 Incidental finding on CXR Resection Unknown
Wouters and Greve 19 None Resection, radiotherapy four years later Recurrence at four years, then
radiotherapy, in remission
Evans et al 61 Chest pain, dyspnoea, pleural effusion Resection Unknown
Wong et al 38 Cough, dyspnoea Resection + radiotherapy Alive at five months
CXR – chest X-ray
Dx – diagnosisPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Cardiothoracic Surgery 2007, 2:48 http://www.cardiothoracicsurgery.org/content/2/1/48
Page 3 of 3
(page number not for citation purposes)
publication [1]. Wouters and Greve reported local relapse
at four years, which was treated with surgery and adjuvant
radiotherapy [5]. This patient remained disease free for a
further four years. Evans et al reported a case without
though mentioning the overall survival period [6]. Wong
et al published a similar report with the patient alive five
months following resection and radiotherapy [2] [Table
1].
We have therefore suggested a treatment pathway in
patients with primary pleural myxoid liposarcoma based
on personal experience and literature evidence [Figure 1].
To conclude myxoid pleural liposarcomas are rare entities
and from the existing literature it is difficult to forecast
prognostic factors which may correlate with long term sur-
vival. Although there is no common consensus, we
believe that aggressive surgical management followed by
radiotherapy is the best treatment modality. If the tumour
is large or complex neoadjuvant radiotherapy could
potentially identify responders; these patients could then
be offered radical surgical treatment for potential long-
term control of the disease.
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